ARTICLE | Company News
Millennium other research news
October 25, 2004 7:00 AM UTC
MLNM's studies using an RA patient registry containing genetic and proteomic data from about 1,000 patients identified biomarkers indicative of treatment success with disease modifying anti-rheumatic ...